Evaluation & Prevalence of Pharmacovigilance:

To increase the safe usage of medicines, it is important that these ADRs be reported. Many countries around the world have well established national Pharmacovigilance systems that depend upon reporting of ADRs by physicians and pharmacists..  This study was carried out to gain insight into the knowledge, attitude, and perception of physicians, pharmacists, and nurses working in the private sector towards Pharmacovigilance and ADR reporting by conducting a questionnaire-based survey. Their knowledge of ADR reporting, the concept of Pharmacovigilance, the type of ADRs that are to be reported are discussed along with their attitude and perception as to how important ADR reporting is. The reasons and factors of under-reporting or not reporting ADRs are also evaluated. In order to achieve the research objectives.

  • Drug safety Monitoring
  • Evaluation Incidence
  • Predictive Analysis
  • Cardiovascular Drug Discovery & Therapy

Related Conference of Evaluation & Prevalence of Pharmacovigilance:

July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Evaluation & Prevalence of Pharmacovigilance: Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in